OIE Procedure for Validation and Certification of Diagnostic Assays

Similar documents
OIE Standard on principles and methods of validation of diagnostic assays for infectious diseases

i) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans.

Reminder (VICH charter)

The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual.

QUALITY MANAGEMENT IN VETERINARY TESTING LABORATORIES

PRINCIPLES OF VALIDATION OF DIAGNOSTIC ASSAYS FOR INFECTIOUS DISEASES

OIE Reference Laboratory Reports Activities

PROCEDURE FOR OFFICIAL RECOGNITION OF DISEASE STATUS UPDATE ON FOOT AND MOUTH DISEASE

OIE Guideline. 1. Introduction

OIE Guideline. International Reference Antibody Standards for Antibody Assays. 1. Introduction

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

ILAC Mutual Recognition Arrangement: Policy and Management ILAC-P4:06/2017

Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

Laboratory Quality Assurance Manager & Laboratory Assessor RULES & HANDBOOK

Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development

A2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017

DESIGNATION AND RESPONSIBILITIES OF OIE NATIONAL FOCAL POINTS

PROFICIENCY TESTING 2013

A24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018

EUROPEAN COMMISSION HEALTH & FOOD SAFETY. Directorate G Veterinary and International affairs. Unit G2- Animal health

Fish Health Laboratory Quality Assurance Process Basic Requirements for Tier I Prequalification

IECEE OPERATIONAL DOCUMENT

Diagnostics. Using Diagnostic Tests. Test Sensitivity and Specificity. Dr. Randall Singer Professor of Epidemiology

Quality Assurance of Investigational Medicinal Products. Sue McKenzie PPQA (A)

INFECTIOUS MYONECROSIS

I: Glossary of Terms. 6 th ed. Paris, France: WOAH; Page 3

Update on the IVDR. Sue Spencer

Quality management in veterinary testing laboratories

OIE Reference Laboratory Reports Activities

Role of an OIE Reference Laboratory Trichinellosis. Edoardo Pozio Istituto Superiore di Sanità Rome, Italy

2nd PPR & 4th FMD Roadmap Meetings for Middle East Amman, October PPR Global Eradication Programme Overview FAO/OIE PPR Secretariat

Michael Robach Vice President, Corporate Food Safety and Regulatory Affairs Cargill incorporated Minneapolis, Minnesota, USA

OIE Reference Laboratory Reports Activities

Guidance for individual laboratories for transfer of quality control methods validated in collaborative trials with a view to implementing 3Rs

ILAC-P10:2002. ILAC Policy on Traceability of Measurement Results

Measurement of uncertainty for Elisa Tests. University of Hasselt, Center for Statistics, Hasselt, Belgium

OIE Reference Laboratory Reports Activities

OIE Regional Commission for Asia, the Far East and Oceania. Second Regional Work Plan Framework

Selection of a cutoff value for real-time polymerase chain reaction results to fit a diagnostic purpose: analytical and epidemiologic approaches

PPR Global Eradication Programme Overview

The FAO-OIE PPR Global Strategy. Outline 1. Establishment of the PPR WG and actions undertaken 2. Components of the strategy

Welding Performance Qualification Test Administrators GUIDE FOR APPLICANTS

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

A Novel Approach to BSL-4 Research: Establishing a Clinical Core Services Group in High Containment

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Validating, Verifying, and Evaluating Your Test Methods: It s NOT a Regulatory Exercise!

Wildlife Health Risk Assessment in Support of Decisions and Policies

The New EU IVDR. Overview of the Main Changes & Clinical Data Requirements. Advance Regulatory Consulting Ltd.

Recognition of Prior Learning (RPL) _v2.2

Title: How to assess a PQS testing laboratory Table of Content

Fibrinogen Universal Kit

National Veterinary Assay Laboratory Ministry of Agriculture, Forestry and Fisheries

ISO INTERNATIONAL STANDARD

OIE STANDARDS ON ANIMAL IDENTIFICATION AND TRACEABILITY, AND THE LEVEL OF COMPLIANCE WITH THESE STANDARDS IN AFRICA

QUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY

Replacing Analytical Methods for Release and Stability Testing CBER Perspective

HUMAN RESOURCES COMMITTEE CHARTER

DEVELOPMENT AND OPTIMISATION OF NUCLEIC ACID DETECTION ASSAYS

EA MULTILATERAL AGREEMENT Facilitating cross border trade with reliable goods and services

REQUEST for the EuroRec Seal - Seal Level 2 Supplier Form

JAA Administrative & Guidance Material Section Six: Synthetic Training Devices (STD/FSTD), Part Three: Temporary Guidance Leaflet

Variation Regulations (EU)

ISTA Tests for GMO seeds : New Rules Chapter and Handbook

American Society of Cytopathology Core Curriculum in Molecular Biology

Update on activities in ISO and CEN. Kirsten Mooijman

OIML B 15 BASIC PUBLICATION. Edition 2006 (E) ORGANISATION INTERNATIONALE INTERNATIONAL ORGANIZATION

Guidelines to establish a National Certification Centre for an assessment system based on the ELAQF Qualification Standards.

Clinical Trials application process, legislation & guidelines

PUBLIC-PRIVATE PARTNERSHIPS: EXPECTATIONS OF PRIVATE SECTOR PARTNERS FOR INTERNATIONAL ANIMAL HEALTH AND LIVESTOCK SECTOR DEVELOPMENT PROGRAMMES

BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE

TECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES

International Association for Biologicals

Billing Contact: Phone: Research Funding: NIH Funded Industry Funded Department Funded Short Study Protocol Title:

OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS

Selection and use of Ebola in vitro diagnostic (IVD) assays

Metrological Traceability and Assay Standardization in Laboratory Medicine. STRESA, ITALY May 24, 2013

How to Choose the Right Equipment/Platforms for your Laboratory

ISTA Accreditation Standard for Seed Testing and Seed Sampling

Code and manual. Aquatic animals

EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL QUESTIONS. and ANSWERS

EURASIAN ECONOMIC COMMISSION COUNCIL

Laboratory Validation. Chapter 16

European Regulations for Medicines. Place and Role of the European Pharmacopoeia in Europe Ph. Eur. concept

SAI Global Full Service Team

Terms and conditions for laboratories appointed to undertake the testing of compost under the Compost Certification Scheme aligned to PAS 100 and the

PHARMACEUTICAL REFERENCE STANDARDS

Explanatory note on general fees payable to the European Medicines Agency

Recast Medical Device directives Impacts on materiovigilance

Recognition of Prior Learning (RPL) & Credit Transfers

A2LA. P113a Policy on Reference Material Traceability for Life Sciences Testing Laboratories

OIE Reference Laboratory Reports Activities

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

LEARNING. Recognition of Prior Learning Policy and Procedure

Flexible, robust solutions from BSI. An In Vitro Diagnostic Notified Body. Expertise and experience. IVD regulatory solutions

Transcription:

OIE Procedure for Validation and Certification of Diagnostic Assays A FRAMEWORK FOR A HARMONISED APPROACH OF THE VALIDATION AND REGISTRATION OF VETERINARY DIAGNOSTIC ASSAYS ACROSS THE WORLD OIE Conference on Veterinary Medicinal Products in the Middle East, Damascus, Syria, December 2009 Dr François Diaz OIE Scientific and Technical Department

Introduction OIE Guidelines and General Principles regarding validation of veterinary diagnostic test methods OIE Procedure for the validation and certification of diagnostic assays Conclusions

OIE Guidelines and General Principles for validation of diagnostic test methods

The relevant OIE Publications Manual of diagnostic tests and vaccines for terrestrial animals (chapter 1.1.4/5 on Principles and Methods of Validation of Diagnostic Assays for Infectious Diseases ) Manual of diagnostic tests for aquatic animals (chapter 1.1.2. identical to the chapter 1.1.4/5 of the Terrestrial Manual) OIE Quality Standard and Guidelines for Veterinary Laboratories: Infectious Diseases (4 Guides)

Chapter 1.1.4/5 of the OIE Terrestrial Manual and 1.1.2. of the Aquatic Manual New chapter resulting from the fusion of the two previous chapters on the validation. 7 Appendixes are in development. Chapter available and downloadable on the OIE website: http://www.oie.int/eng/normes/mmanual/a_summry.htm http://www.oie.int/eng/normes/fmanual/a_summry.htm

OIE Quality standard and Guidelines for Veterinary Laboratories OIE quality standard for veterinary laboratories + 4 Guides: 1. Validation of Diagnostic Assays for Infectious Diseases 2. Validation and Quality Control of PCR Methods used for the Diagnosis of Infectious Diseases 3. International Reference Antibody Standards for Antibody Assays 4. Laboratory Proficiency Testing

OIE Quality standard and Guidelines for Veterinary Laboratories According to this OIE quality standard: A test method shall be considered appropriate for routine diagnostic purposes only if it has been validated according to the principles outlined in the OIE Manual and other related OIE references

Content of the OIE Guidelines and General Principles Definition of the validation: The validation of a diagnostic test method is a process that determines the fitness of the test method, which has been properly developed, optimised and standardised, for an intended purpose. It is an ongoing process.

Content of the OIE Guidelines and General Principles The most common purposes are to: Demonstrate freedom from infection in a defined population (country/zone/compartment/herd) Free with and/or without vaccination, Historical freedom, Reestablishment of freedom after outbreaks Certify freedom from infection or presence of the agent in individual animals or products for trade/movement Eradication of diseases or elimination of infection from defined populations Confirmatory diagnosis of suspect or clinical cases Estimate prevalence of infection or exposure to facilitate risk analysis Determine immune status of individual animals or populations

Content of the OIE Guidelines and General Principles OIE validation pathway: 4 stages defined The validation includes estimates of the analytical and diagnostic performance characteristics of a test. The OIE has defined the following chronological validation pathway: Stage 1 : Analytical performance characteristics Stage 2 : Diagnostic performance of the assay Stage 3 : Reproducibility Stage 4 : Programme implementation

Content of the OIE Guidelines and General Principles Stage 1 : Analytical performance characteristics Analytical sensitivity : smallest detectable amount of analyte that can be measured with a defined certainty Analytical specificity : Degree to which the assay distinguishes between the target analyte and other components in the sample matrix Repeatability: Level of agreement between replicates of a sample both within and between runs of the same test method in a given laboratory

Content of the OIE Guidelines and General Principles Stage 2 : Diagnostic performance of the assay Selection of reference animals Diagnostic specificity : Proportion of known uninfected reference animals that test negative in the assay Diagnostic sensitivity : Proportion of known infected reference animals that test positive in the assay Comparison with existing diagnostic test Final Threshold determination

Content of the OIE Guidelines and General Principles Stage 3 : Reproducibility Definition: ability of a test method to provide consistent results when applied to aliquots of the same samples tested at different laboratories Provides additional data for the estimation of the repeatability Provides data on the ruggedness if the test method has been developed as a diagnostic kit.

Content of the OIE Guidelines and General Principles Stage 4 : Programme implementation Extensive application of the test method in different laboratories Organisation of regular proficiency testing Monitoring the assay Consideration for other purposes

Fitness of Assay for its Intended Purpose Assay Development Pathway Essential Prerequisites Study Design and Protocol Reagents and Controls Optimization, Robustness, Calibration to Standards Analytical Specificity Analytical Sensitivity Provisional Recognition STAGE 1 Analytical characteristics Repeatability and preliminary Reproducibility Candidate test compared with Standard Test Method Assay Validation Pathway Diagnostic Analytical Specificity Diagnostic Sensitivity Cut-off determination STAGE 2 Diagnostic characteristics Samples from reference animals Samples from experimental animals (where used) Select collaborating Labs STAGE 3 Reproducibility Define evaluation panel Reproducibility Ruggedness Interpretation of test results Deployment to other Labs STAGE 4 Implementation Reference standards selected International recognition (OIE) Validation status retention Replacement of depleted reagents Assay modifications and re-validation Equivalency assessments Monitoring and maintenance of validation criteria Monitor precision and accuracy Daily in-house QC Proficiency testing

OIE Procedure for the validation and certification of diagnostic assays

Aim and Scope of the Procedure Developed to meet the needs of OIE Member, the aim of this procedure is: 1. to certify a kit as validated fit for purpose. 2. to produce an OIE register of recognised diagnostic kits (available on the OIE web site). All diagnostic tests for diseases, including zoonosis, caused by pathogens present in animals can be validated and certified by the OIE procedure.

OIE Procedure for validation and certification of diagnostic assays Briefly 1/2 Procedure based on the submission of a dossier by a kit manufacturer wishing to have the kit certified by the OIE Dossier, that has to be filled in, downloadable from the OIE website The data in the dossier are presented according to the 4 stages defined by the OIE for the validation of a test method.

OIE Procedure for validation and certification of diagnostic assays Briefly 2/2 Administrative revision to check if the dossier is complete Scientific evaluation of the dossier by a group of 2 3 independent and internationally recognised experts If the kit goes successfully through the procedure, it is proposed by the Biological Standards Commission for inclusion in the Register to the vote of the World Assembly of Delegates OIE Register currently comprises 5 diagnostic kits certified (kits for Rabies, BSE/TSE, White Spot Disease, AI)

OIE Procedure for validation and certification of diagnostic assays Outline of all the process Applicant Contact Dossier + Fees OIE Secretariat for the Procedure Validation of content of the dossier Appoint assessors Additional information 30 d Further assesment Assessment Meeting of the BSC 135d Decision Notification Appeals procedure Inclusion on the OIE Register

OIE Register available on the OIE Web site

Conclusions Framework for a harmonised approach across the world Keep on improving, when relevant, the OIE Guidelines and Principles and the Procedure Keep on encouraging application of the OIE Standards

Thank you for your attention Organisation Mondiale de la Santé Animale World Organisation for Animal Health Organización Mundial de Sanidad Animal 12 rue de Prony, 75017 Paris, France - www.oie.int oie@oie.int